GEROLDI, DIEGO
 Distribuzione geografica
Continente #
NA - Nord America 2.595
EU - Europa 1.996
AS - Asia 1.876
SA - Sud America 195
AF - Africa 22
OC - Oceania 6
Totale 6.690
Nazione #
US - Stati Uniti d'America 2.554
CN - Cina 1.152
IE - Irlanda 462
SG - Singapore 379
UA - Ucraina 299
FI - Finlandia 271
DE - Germania 260
RU - Federazione Russa 223
HK - Hong Kong 171
BR - Brasile 165
GB - Regno Unito 143
SE - Svezia 95
IT - Italia 93
VN - Vietnam 69
FR - Francia 49
BE - Belgio 26
CA - Canada 26
IN - India 22
PL - Polonia 20
NL - Olanda 15
ES - Italia 14
JP - Giappone 14
BD - Bangladesh 13
ZA - Sudafrica 12
AR - Argentina 10
TR - Turchia 10
IQ - Iraq 9
MX - Messico 9
CZ - Repubblica Ceca 6
EC - Ecuador 6
ID - Indonesia 6
AU - Australia 5
SA - Arabia Saudita 5
JO - Giordania 4
AT - Austria 3
CO - Colombia 3
IL - Israele 3
KE - Kenya 3
LT - Lituania 3
PE - Perù 3
UZ - Uzbekistan 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
BO - Bolivia 2
CL - Cile 2
MA - Marocco 2
MU - Mauritius 2
MY - Malesia 2
NO - Norvegia 2
NP - Nepal 2
PK - Pakistan 2
QA - Qatar 2
RO - Romania 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
TJ - Tagikistan 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BW - Botswana 1
BY - Bielorussia 1
CH - Svizzera 1
CR - Costa Rica 1
CU - Cuba 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
HU - Ungheria 1
IR - Iran 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LV - Lettonia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PT - Portogallo 1
PY - Paraguay 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
Totale 6.690
Città #
Dublin 462
Chandler 457
Jacksonville 337
Nanjing 272
Beijing 214
Singapore 189
Hong Kong 171
Ashburn 169
Dallas 167
Boardman 124
Ann Arbor 116
Nanchang 104
Helsinki 97
Los Angeles 84
Munich 80
Princeton 80
Lawrence 73
Hebei 70
Shenyang 69
Changsha 66
Medford 66
Jiaxing 54
New York 54
Wilmington 50
Moscow 45
Tianjin 44
Hangzhou 42
Shanghai 36
Buffalo 32
Turku 29
Woodbridge 29
Brussels 26
Milan 22
São Paulo 22
Verona 22
Seattle 21
Hanoi 19
Ho Chi Minh City 19
Norwalk 18
Brooklyn 15
Redondo Beach 13
Des Moines 12
Pavia 12
Piscataway 12
Warsaw 12
Tokyo 11
Auburn Hills 10
Denver 10
Fairfield 10
Johannesburg 10
London 10
Rio de Janeiro 9
Toronto 9
Chennai 8
Montreal 8
Poplar 8
Santa Clara 8
Jinan 7
Manchester 7
Washington 7
Zhengzhou 7
Orem 6
Taizhou 6
Berlin 5
Frankfurt am Main 5
Haiphong 5
Houston 5
Kunming 5
Mexico City 5
Ningbo 5
Stockholm 5
Amman 4
Amsterdam 4
Atlanta 4
Biên Hòa 4
Campinas 4
Changchun 4
Chicago 4
Falkenstein 4
Hanover 4
Istanbul 4
Lanzhou 4
Mumbai 4
Naples 4
The Dalles 4
Belo Horizonte 3
Boston 3
Charleston 3
Curitiba 3
Franca 3
Guayaquil 3
Ichibancho 3
Maricá 3
Nairobi 3
Orange 3
Ottawa 3
Phoenix 3
Porto Alegre 3
Pune 3
San Francisco 3
Totale 4.419
Nome #
Plasma eotaxin concentrations are associated with angiographic severity of coronary artery disease 134
Significance of apolipoprotein(a) phenotypes in acute coronary syndromes: relation with clinical presentation. 129
Absence of Kir6.1/KCNJ8 mutations in Italian patients with abnormal coronary vasomotion 124
Relationship between apolipoprotein(a) size polimorphism and coronary heart disease in overweight subjects 122
Significato prognostico dei livelli plasmatici di osteopontina in pazienti con angina pectoris stabile 122
RAGE : a central player in nondiabetic vascular disease 120
QT interval duration in apparently healthy men is associated with depression-related personality trait neuroticism 119
La chemochina regolatoria eotaxina-3 quale nuovo fattore predittivo di outcome cardiovascolare in pazienti con angina pectoris stabile 118
Decreased NT-3 plasma levels and platelet serotonin content in patients with hypochondriasis 118
Relationship between plasma levels of soluble receptor for advanced glycation end products (sRAGE) and coronary artery disease 117
Diabetes mellitus and silent myocardial ischemia in patients with coronary artery disease: comparison between patients with and without simptoms during provocative test. 116
Apo(a) isoforms: a genetic marker for progression of coronary atherosclerosis. 116
Approccio genetico-clinico alla cardiopatia ischemica: analisi di 14 casi familiari. 115
A novel Val734Ile variant in the ABCC9 gene associated with myocardial infarction 114
374T/A polymorphism of the RAGE gene promoter in relation to severity of coronary atherosclerosis 113
Decreased plasma levels of soluble receptor for advanced glycation end-products in patients with essential hypertension 110
Association of lipoprotein(a) levels and apolipoprotein(a) phenotypes with coronary heart disease in patients with essential hypertension 110
Association of lipoprotein(a) levels and apolipoprotein(a) phenotypes with coronary artery disease in Type 2 diabetic patients and in non-diabetic subjects 110
The apolipoprotein(a) component of lipoprotein(a) mediates binding to laminin:contribution to selective retention of lipoprotein(a) in atherosclerotic lesions. 109
Forma solubile del recettore dei prodotti finali di glicazione avanzata (sRAGE) ed aterosclerosi coronarica 109
Circulating levels of osteopontin predicts future cardiac events in patients with chronic stable angina 108
Analisi mutazionale di Kir6.1/KCNJ8 in pazienti con angina vasospastica 107
Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men 106
Analysis of the apoliporotein(a) size polymorphism in patients with systemic lupus erythematosus 106
Matrix metalloproteinase 2 may be a marker of microangiopathy in children and adolescents with type 1 diabetes 104
Analysis of the apolipoprotein(a) size polymorphism in patients with systemic lupus erythematosus 104
Association of plasma eotaxin levels with the presence and extent of angiographic coronary artery disease 103
The regulatory chemokine eotaxin-3 is a novel predictor of cardiovascular outcome in patients with coronary artery disease 102
Association between low-molecular weight apolipoprotein(a) isoforms and obesity in Italian women 101
Cerebral ischemia and peripheral energy dysfunction in lymphocytes 101
Matrix metalloproteinase 2 may be a marker of microangiopathy compared to metalloproteinase 9 in children and adolescents with type 1 diabetes mellitus: A 5 year follow-up study 101
High levels of soluble receptor for advanced glycation end products may be a marker of extreme longevity in humans 99
Raised plasma nerve growth factor levels associated with early-stage romantic love 98
Analysis of the apolipoprotein(a) size polymorphism in patients with systemic lupus erythematosus. 97
Disfunzione erettile come predittore di eventi cardiovascolari maggiori in diabetici con coronaropatia silente angiograficamente documentata 95
Association between apolipoprotein(a) phenotypes and coronary heart disease at a young age. 95
ATPases enzyme activities during ageing in different types of somatic and synaptic plasma membranes from rat frontal cerebral cortex 94
Assessment of asymptomatic coronary artery disease in apparently uncomplicated type 2 diabetic patients: a role for lipoprotein(a) and apolipoprotein(a) polymorphism. 94
Action of piracetam and clonidine on different mitochondrial populations from hippocampus 92
Elevated plasma levels of lipoprotein(a) in psychiatric patients: a possible contribution to increased vascular risk 91
Apolipoprotein(a) phenotypes are reliable biomarkers for familial aggregation of coronary heart disease 89
Functional proteomics of energy-linked enzymes in lymphocytes after stroke. 87
Silent myocardial ischemia in diabetic and nondiabetic patients with coronary artery disease. 85
Apolipoprotein(a) phenotypes and their predictive value for coronary heart disease: identification of an operative cut-off of apolipoprotein(a) polymorphism. 84
Circulating levels of soluble receptor for advanced glycation end products in neurodegenerative and vascular dementia 83
Prognostic significance of plasma osteopontin levels in patients with chronic stable angina 82
Enzyme activities in perikaryal and synaptic mitochondrial fractions from rat hippocampus during development 81
Markers of eosinophilic inflammation and risk prediction in patients with coronary artery disease 81
Matrix metalloproteinase 2 may be a marker of microangiopathy compared to metalloproteinase 9 in children and adolescents with type 1 diabetes mellitus: a 5-year follow-up study 80
Relationship between erectile dysfunction and silent myocardial ischemia in apparently uncomplicated type 2 diabetic patients 79
Matrix metalloproteinase 2 and 9 evaluation in patients with or without diabetes during acute coronary syndrome and after the acute event 78
Genetic loading on human loving styles 78
The -374T/A RAGE polymorphism protects against future cardiac events in nondiabetic patients with coronary artery disease. 77
Matrix metalloproteinase 2 may be a marker of microangiopathy in children and adolescents with type 1 diabetes mellitus 76
Soluble receptor for advanced glycation end products: from disease marker to potential therapeutic target 75
Increased Plasma Aldosterone Concentrations in Patients with Clinical Depression 75
High Lp(a) levels and atherogenic isoforms in patients with acute coronary sindrome 74
Restenosis after intracoronary stent placement: can apolipoprotein(a) polymorphism play a role? 71
The apolipoprotein(a) size polymorphism is assocated with Alzheimer's disease and vascular dementia 70
Fenotipi di apolipoproteina(a) come indicatori di suscettibilità genetica per rischio cardiovascolare in medicina del lavoro 69
Factors involved in drug interference on enzyme activities of three mitochondrial populations from rat hippocampus 68
Erectile dysfunction and angiographic extent of coronary artery disease in type II diabetic patients 66
Metalloproteinase-2 and -9 in diabetic and nondiabetic subjects during acute coronary syndromes 65
Valutazione delle metalloproteasi 2 e 9 in pazienti con o senza diabete durante sindrome coronarica acuta e dopo evento acuto 64
Energy metabolism of mitochondria after ischemia and recovery times during aging and peripheral energy dysfunction in stroke patients: focus on lymphocytes 63
Peripheral energy dysfunction in cerebral ischemia: focus on lymphocytes. 63
Mitochondrial Energy Metabolism of Brain and Lymphocytes after Ischemia and Recovery during Aging 63
Energy metabolism of lymphocytes from acute stroke patients 61
Prevalenza di elevati livelli di Lp(a) e di isoforme aterogene in un gruppo di pazienti del Nord Italia con sindrome coronarica acuta 60
Relationship between platelet serotonin content and rejections of unfair offers in the ultimatum game. 59
Relationship between apolipoprotein(a) size polymorphism and coronary heart disease in overweight subjects 56
Lymphocytes bioenergetics after stroke: a functional proteomic study 56
Mitochondrial Energy Metabolism of Brain and Lymphocytes after Ischemia and Recovery during Aging 54
Totale 6.715
Categoria #
all - tutte 26.088
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.088


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021321 0 0 0 0 0 73 7 71 15 74 66 15
2021/2022326 7 3 9 8 2 5 8 20 16 19 49 180
2022/20231.338 139 107 17 98 149 124 0 78 556 17 34 19
2023/2024424 77 85 11 26 34 95 4 37 3 13 19 20
2024/20251.128 18 82 50 32 34 38 44 80 290 33 149 278
2025/20261.276 219 140 258 304 325 30 0 0 0 0 0 0
Totale 6.715